PPAR gamma, agonists

Name
PPAR gamma, agonists
Accession Number
DBCAT001710
Description

Not Available

Drugs
DrugDrug Description
AMG-131Investigated for use/treatment in diabetes mellitus type 2.
MuraglitazarInvestigated for use/treatment in diabetes mellitus type 2.
LobeglitazoneLobeglitazone was approved by the Ministry of Food and Drug Safety (South Korea) in 2013, and is being monitored by postmarketing surveillance until 2019. Lobeglitazone is not approved for use...
NaveglitazarNaveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent.
Drugs & Drug Targets
DrugTargetType
AMG-131Peroxisome proliferator-activated receptor gammatarget
MuraglitazarPeroxisome proliferator-activated receptor alphatarget
MuraglitazarPeroxisome proliferator-activated receptor gammatarget
MuraglitazarCytochrome P450 1A2enzyme
MuraglitazarUDP-glucuronosyltransferase 1-3enzyme
MuraglitazarUDP-glucuronosyltransferase 1-1enzyme
MuraglitazarCytochrome P450 2C8enzyme
LobeglitazoneSolute carrier organic anion transporter family member 1B1transporter
LobeglitazoneSolute carrier organic anion transporter family member 3A1transporter
LobeglitazoneP-glycoprotein 1transporter
LobeglitazoneCytochrome P450 1A2enzyme
LobeglitazoneCytochrome P450 2C9enzyme
LobeglitazoneCytochrome P450 2C19enzyme
LobeglitazonePeroxisome proliferator-activated receptor gammatarget
LobeglitazoneCytochrome P450 3A4enzyme
LobeglitazoneCytochrome P450 2C8enzyme
NaveglitazarPeroxisome proliferator-activated receptor gammatarget